Harbor Advisors LLC Nektar Therapeutics Transaction History

Harbor Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$30.43 - $56.65 $182,580 - $339,900	-6,000 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$46.25 - $104.45 $185,000 - $417,800	4,000 Added 200.0%	6,000 $293,000
Q1 2018 May 11, 2018	BUY	$57.4 - $108.44 $114,800 - $216,880	2,000 New	2,000 $213,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Harbor Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Advisors LLC with notifications on news.